3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
1
Interventions
Specimen Handling
190
Magnetic Resonance Spectroscopy
141
Biopsy
101
pembrolizumab
82
Carboplatin
77
Cisplatin
69
Nivolumab
61
Radiotherapy
50
Paclitaxel
50
Gemcitabine
50
Dexamethasone
45
Cyclophosphamide
45
atezolizumab
38
Radiation
38
Pemetrexed
38
durvalumab
36
venetoclax
32
Etoposide
32
Bevacizumab
32
olaparib
31
Lenalidomide
31
X-Rays
30
Rituximab
30
Docetaxel
30
Doxorubicin
29
Disulfides
28
Prednisone
27
Immunoglobulin G
27
Vincristine
26
Ipilimumab
26
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Chemoradiotherapy, Adjuvant
×
30 days
×
Clear all
NCT05667298
2026-05-11
OPERARADIO
University of Manitoba
Phase 1
Active not recruiting
11 enrolled